On September 2, 2025, Marieke Vinkenoog and Simon Christian Hansmann were honored with the Krijn Rietveld Memorial Innovation Awards for their research in blood donation and colorectal cancer. Vinkenoog received the Doctoral Societal Impact Award for her development of data-driven models that predict donor hemoglobin levels, enhancing the efficiency of blood donation processes. Hansmann was awarded the Graduate Societal Impact Award for his use of 3D cell models to identify cancer cells responsible for tumor recurrence, potentially informing future therapeutic strategies. The awards, presented by the Leiden University Fund and dsm-firmenich, recognize innovative research with significant societal impact.
If approved, Joenja will be the first approved treatment in the U.S. for children with activated phosphoinositide 3-kinase delta (PI3Kδ) syndrome (APDS), a rare primary immunodeficiency disorder. The resubmission of the supplemental New Drug Application (sNDA) seeks approval for dosages…
